# \[e-drug\] Time needed to provide bioequivalence studies (cont'd)

**URL:** <https://talk.edrugplus.org/t/e-drug-time-needed-to-provide-bioequivalence-studies-contd/12664>\
**Category:** e-drug\
**Created:** [October 11, 2001, 10:12pm UTC](https://talk.edrugplus.org/t/e-drug-time-needed-to-provide-bioequivalence-studies-contd/12664 "2001-10-11T22:12:09Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![love](https://avatars.discourse-cdn.com/v4/letter/l/dec6dc/32.png) [@love](https://talk.edrugplus.org/u/love)\
**Post date:** [October 11, 2001, 10:12pm UTC](https://talk.edrugplus.org/t/e-drug-time-needed-to-provide-bioequivalence-studies-contd/12664/1 "2001-10-11T22:12:09Z")

</div>

E-drug: Time needed to provide bioequivalence studies (cont'd)  
-------------------------------------------------------------------------

Would 3 to 6 or 9 months, for everything, be typical in RSA? And  
how much is "very costly?" Would it typically cost more or less  
than $100,000 USD for a product? Also, is there ever any delay in  
scheduling the tests? I have heard this is a problem sometimes. And  
for a layman, can you explain why the companies don't like to  
share this information widely?

Jamie

James Love  
Consumer Project on Technology  
P.O. Box 19367, Washington, DC 20036  
[http://www.cptech.org](http://www.cptech.org), [mailto:love@cptech.org](mailto:love@cptech.org)  
voice: 1.202.387.8030 fax 1.202.234.5176 mobile  
1.202.361.3040

--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Information and archive [http://satellife.healthnet.org/programs/edrug.html](http://satellife.healthnet.org/programs/edrug.html)  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
